Search Results - "Kok, K B"

P120 A novel population of classical monocytes is expanded in CD and defined by an upregulation of genes relating to mononuclear cell differentiation and response to microbes by Gadhok, R, Hornsby, E, Kok, K B, Lindsay, J O, Stagg, A J

“…Abstract Background In Crohn's disease (CD), differentiation of classical blood monocytes to intestinal macrophages in the mucosa generates inflammatory rather…”
Get full text

P039 The role of α4β7+CLA+ ‘dual tropic’ T cells in inflammatory bowel disease by Gordon, H, Rodger, B, Hornsby, E, McGuire, J, Kok, K B, Lindsay, J O, Stagg, A J

“…Abstract Background Upon activation, T cells upregulate cell-surface molecules that enable entry into peripheral tissues. Retinoic acid (RA) produced by gut DC…”
Get full text

OP01 PROFILE: a multi-centre, randomised, open-label, biomarker-stratified clinical trial of treatment strategies for patients with newly-diagnosed Crohn’s disease by Noor, N, Lee, J, Bond, S, Dowling, F, Brezina, B, Patel, K, Ahmad, T, Banim, P, Cooney, R, De La Revilla Negro, J, de Silva, S, Din, S, Durai, D, Gordon, J, Irving, P, Johnson, M, Kent, A, Kok, K B, Moran, G, Patel, P, Probert, C, Raine, T, Saich, R, Seward, A, Sharpstone, D, Smith, M, Subramanian, S, Upponi, S, Wiles, A, van den Brink, G, Vermeire, S, Jairath, V, D'Haens, G, McKinney, E, Lyons, P, Lindsay, J, Kennedy, N, Smith, K, Parkes, M

“…Abstract Background Clinical outcomes differ substantially between patients with Crohn’s disease and there is variability in how newly-diagnosed patients are…”
Get full text

P507 Ustekinumab: Medium-term outcomes from a UK multicentre real-world cohort by Gadhok, R, Fragkos, K, Honap, S, Hassan, J, Whiteley, L, Ibarra, A, Burgess, N, Vega, R, Seward, E, Mehta, S, McCartney, S, Bloom, S, Parkes, G, Irving, P, Lindsay, J O, Kok, K B, Rahman, F

“…Abstract Background Ustekinumab is effective at inducing and maintaining remission of Crohn’s disease (CD) in clinical trials. However real-world practice may…”
Get full text

OP22 Antibody decay, T cell immunity and breakthrough infections following SARS-CoV-2 vaccination in infliximab- and vedolizumab-treated patients by Lin, S, Kennedy, N A, Saifuddin, A, Muñoz Sandoval, D, Reynolds, C J, Seoane, R C, Kottoor, S H, Pieper, F P, Lin, K M, Butler, D K, Chanchlani, N, Nice, R, Chee, D, Bewshea, C, Janjua, M, McDonald, T J, Sebastian, S, Alexander, J L, Constable, L, Lee, J C, Murray, C D, Hart, A L, Irving, P M, Jones, G R, Kok, K B, Lamb, C A, Lees, C W, Altmann, D M, Boyton, R J, Goodhand, J R, Powell, N, Ahmad, T

“…Abstract Background Antibody responses following SARS-CoV-2 infection or a single-dose of SARS-CoV-2 vaccine are impaired in patients with inflammatory bowel…”
Get full text

DOP29 Pregnancy outcomes in IBD patients treated with vedolizumab, anti-TNF, or conventional therapy by Moens, A, van der Woude, C, Julsgaard, M, Sebastian, S, Arebi, N, Alzinaty, M, Humblet, E, Kok, K B, Sheridan, J, Gilletta De Saint-Joseph, C, Nancey, S, Rahier, J-F, Bossuyt, P, Cremer, A, Dewit, S, Eriksson, C, Hoentjen, F, Krause, T, Louis, E, Macken, E, Milenkovic, Z, Nijs, J, Posen, A, Van Hootegem, A, Van Moerkercke, W, Vermeire, S, Bar-Gil Shitrit, A, Ferrante, M

“…Abstract Background Women with inflammatory bowel diseases (IBD) often receive biologicals during pregnancy to maintain disease remission prior to conception…”
Get full text

Pregnancy outcomes in IBD patients treated with vedolizumab, anti-TNF, or conventional therapy by Moens, A., van der Woude, C., Julsgaard, M., Sebastian, S., Arebi, N., Alzinaty, M., Humblet, E., Kok, K. B., Sheridan, J., De Saint-Joseph, C. Gilletta, Nancey, S., Rahier, J. -F, Bossuyt, P., Cremer, A., Dewit, S., Eriksson, Carl, Hoentjen, F., Krause, T., Louis, E., Macken, E., Milenkovic, Z., Nijs, J., Posen, A., Van Hootegem, A., Van Moerkercke, W., Vermeire, S., Shitrit, A. Bar-Gil, Ferrante, M.

Get full text

Effects of spreading chip waveform pulse-shaping on the performance of DS-CDMA indoor radio personal communication systems in a frequency-selective Rician fading channel by Boon Kiong Kok, Do, M.A.

“…A direct-sequence CDMA (DS-CDMA) mobile radio personal communication system operating over an indoor, Rician fading channel employing differential phase shift…”
Get full text